U.S. stocks rallied Friday, extending a string of sharp moves, amid upbeat economic news from the U.S. and rising hopes for more stimulus from global central banks.

Rockwell Medical, Inc. a fully integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services. Horizon Pharma plc announced the presentation of data from a Phase 2 clinical study of ACTIMMUNE

Insider buying decreased with insiders purchasing $137.24 million of their stock last week compared to $144.43 million in the week prior. Selling also decreased with insiders selling $1.06 billion of stock last week compared to $2.32 billion in the week prior.